Interstitial Pneumonitis Related to Pegylated Interferon
Alfa-2a Treatment in a Patient with Chronic Hepatitis C
Erhan Alkan, Mete Akin, Haydar Adanir, Yasar Tuna
Citation Information :
Alkan E, Akin M, Adanir H, Tuna Y. Interstitial Pneumonitis Related to Pegylated Interferon Alfa-2a Treatment in a Patient with Chronic Hepatitis C. Euroasian J Hepatogastroenterol 2016; 6 (1):91-92.
Fried MW. Side effects of therapy of hepatitis C and their management. Hepatology 2002 Nov;36(5 Suppl 1):S237-S244
Significant pulmonary toxicity associated with interferon and ribavirin therapy for hepatitis C. Am J Gastroenterol 2002 Sep;97(9):2432-2440
Spectrum of pulmonary Toxicity associated with use of interferon therapy for hepatitis C. Case report and review of literature. Clin Infect Dis 2004 Dec;39(11):1724-1729
Side effects of high-dose interferon therapy for chronic hepatitis C. J Hepatol 1996 Sep;25(3):283-291
Pneumonitis as a consequence of (peg)interferon-ribavirin combination therapy for hepatitis C: a review of the literature. Dig Dis Sci 2010 Mar;55(3):579-585
Interstitial pneumonitis associated with pegylated interpheron- alfa 2a and ribavirin for chronic hepatitis C virus infection: a case report. Cases J 2009 Mar 10;2:6464
Pneumonitis during interferon and/or herbal drug therapy in patients with chronic active hepatitis. Eur Respir J 1996 Dec;9(12):2691-2696
